Please log in
You must be logged in to send the contact request.
Manage stand orders
Select Option
ACON Laboratories, Inc.
10125, Mesa Rim Road,
92121
San Diego, CA
USA
USA
Submit your contact details
Provide your contact details to the exhibitor. Optionally, you may also add a personal message.
Your name, phone number, and e-mail address are subject to the submission of personal data. Messe Düsseldorf GmbH expressly points out that for a data transmission into third countries, for which no adequacy decision of the EU-commission is on hand certifying an adequate level of protection of personal data, it is not ensured that there are appropriate safeguards for the protection of personal data on hand.
An error has occurred
Please check your internet connection or try again later.
Message has been sent
Your message to the exhibitor was sent successfully.
Contact
Tiffany Oberman
Email
info@aconlabs.com
Our range of products
Product categories
- 03 Diagnostic tests
- 03.01 Clinical chemistry
- 03.01.01 Glucose testing
Glucose testing
- 03 Diagnostic tests
- 03.01 Clinical chemistry
- 03.01.03 Urinalysis equipment and systems
Urinalysis equipment and systems
- 03 Diagnostic tests
- 03.02 Immunochemistry testing, immunology testing
- 03.02.02 Diagnostic rapid tests
Diagnostic rapid tests
- 03 Diagnostic tests
- 03.05 Infectious immunology testing
- 03.05.03 Other infectious immunology testing
Other infectious immunology testing
- 03 Diagnostic tests
- 03.06 Genetic testing, molecular diagnostics
- 03.06.03 Polymerase chain reaction (PCR)
Polymerase chain reaction (PCR)
Our products
Product category: Other infectious immunology testing
Foresight® SARS-CoV-2 IgG and IgM
The Foresight® SARS-CoV-2 IgG and IgM EIA Test Kits are qualitative enzyme immunoassays for the detection of IgG or IgM antibodies to SARS-CoV-2 in human serum or plasma.
The Foresight® SARS-CoV-2 IgG and IgM EIA Test Kits are only intended for assisting detection of suspected cases with nucleic acid negative, or combining with nucleic acid detection in the diagnosis of suspected cases. Results from Foresight® SARS-CoV-2 IgG and IgM testing should not be used as the sole basis to diagnosis or exclude SARS-CoV-2 infection.
The Foresight® SARS-CoV-2 IgG and IgM EIA Test Kits are only intended for assisting detection of suspected cases with nucleic acid negative, or combining with nucleic acid detection in the diagnosis of suspected cases. Results from Foresight® SARS-CoV-2 IgG and IgM testing should not be used as the sole basis to diagnosis or exclude SARS-CoV-2 infection.
Product category: Glucose testing
On Call® Blood Glucose Monitoring Systems
Carefully designed for accuracy and reliability, the On Call® Blood Glucose Meter Family has helped millions of patients worldwide effectively manage their glucose levels. The foundation for successfully managing your diabetes starts with your meter.
By choosing On Call®, you can rest assured knowing your meter is more than a means to accurate results; it is the cornerstone in your diabetes management.
By choosing On Call®, you can rest assured knowing your meter is more than a means to accurate results; it is the cornerstone in your diabetes management.
Product category: Polymerase chain reaction (PCR)
Promotor® Molecular Diagnostics
Promotor® Nucleic Acid Extraction
- NES-32 Nucleic Acid Extraction System
- Nucleic Acid Extraction Kits
- 960 Real-Time PCR System
- PCR Test Kits - SARS-CoV-2, HBV, HCV, HPV 16/18, HPV Genotyping PCR RDB, TB and HLA-B27
Product category: Diagnostic rapid tests, Urinalysis equipment and systems
Mission® Point-of-care Testing (POCT)
Our product offering includes:
- Urinalysis - urine strips, analyzers and controls
- Cholesterol, Coagulation and Hemoglobin Monitoring - handheld devices and test strips for home and professional use.
Product category: Glucose testing
CentriVet® Animal Health
It is a family of products dedicated to the well-being of our animal friends, large and small. Stemming from years of experience in the medical device arena, our product offering includes a dual Ketone/Glucose meter, as well as urine reagent test strips.
Product category: Other infectious immunology testing
Foresight® EIA Kits
EIA Kits:
- Allergen - Qualitative detection of circulating allergen-specific Immunoglobulin E (IgE ) in human serum.
- Fertility - hCG, FSH, LH and Prolactin-PRL
- Infectious Disease - H.pylori Antigen, H.pylori IgG, HBcAb, HBeAb, HBeAg, HBsAb, HBsAb Quantitative, HBsAg, HCV, HEV IgM, HIV 1/2/O Ab, HTLV I/II and Syphilis
- Thyroid - Free T3, Free T4, Total T3, Total T4 and TSH
- ToRCH - Toxoplasma IgG, Toxoplasma IgM, Rubella IgG, Rubella IgM, CMV IgG, CMV IgM, HSV 1 IgG, HSV 1 IgM, HSV 1/2 IgG, HSV 1/2 IgM, HSV 2 IgG and HSV 2 IgM
- Tumor Markers - AFP, CEA and Total PSA
Company news
Date
Topic
Download
Nov 12, 2020
ACON announces the launch of its Flowflex™ Antigen COVID-19 Test
San Diego, CA, November 2, 2020 — ACON Laboratories, Inc., a leading global medical device manufacturer announced today the launch of its Flowflex™ SARS-COV-2 Antigen Rapid Test. The Flowflex SARS-CoV-2 Antigen Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection the nucleocapsid protein antigen from SARS-CoV-2 in nasal swab specimens.
ACON’s test is intended to help in the diagnosis of individuals who are suspected of active COVID-19 disease by their healthcare provider within the first seven (7) days of the onset of symptoms.
“Our state-of-the-art production facilities, and reputation for manufacturing excellence, make ACON the partner you rely on for your COVID-19 test procurements” said Jinn-nan Lin, President of ACON Laboratories. ”We are proud to provide reliable COVID-19 testing solutions to our worldwide distributors.”
ACON’s COVID-19 test is CE marked and will be commercialized in the European Union and the Latin American Markets.
ACON’s COVID-19 lateral flow chromatographic immunoassay has a high relative sensitivity and specificity and is therefore highly reliable. The Rapid Test is performed using nasal specimens. Results are available after 15 minutes.
ACON is ramping up its manufacturing capabilities to meet the increasing worldwide market demand for reliable testing.
ACON’s test is intended to help in the diagnosis of individuals who are suspected of active COVID-19 disease by their healthcare provider within the first seven (7) days of the onset of symptoms.
“Our state-of-the-art production facilities, and reputation for manufacturing excellence, make ACON the partner you rely on for your COVID-19 test procurements” said Jinn-nan Lin, President of ACON Laboratories. ”We are proud to provide reliable COVID-19 testing solutions to our worldwide distributors.”
ACON’s COVID-19 test is CE marked and will be commercialized in the European Union and the Latin American Markets.
ACON’s COVID-19 lateral flow chromatographic immunoassay has a high relative sensitivity and specificity and is therefore highly reliable. The Rapid Test is performed using nasal specimens. Results are available after 15 minutes.
ACON is ramping up its manufacturing capabilities to meet the increasing worldwide market demand for reliable testing.
About us
Company details
The ACON name is well known in over 130 countries.
For over 23 years, ACON has led the way in making high quality diagnostic and medical devices more affordable to people all around the world.
Headquartered in San Diego, California, the US office is the center of strategic management, administration, business development, innovative research and development. Our state of the art manufacturing facility located in Hangzhou, China is ISO13485: 2016 certified, FDA registered, and has been inspected by US FDA.
For over 23 years, ACON has led the way in making high quality diagnostic and medical devices more affordable to people all around the world.
Headquartered in San Diego, California, the US office is the center of strategic management, administration, business development, innovative research and development. Our state of the art manufacturing facility located in Hangzhou, China is ISO13485: 2016 certified, FDA registered, and has been inspected by US FDA.
Company data
Area of businessDiagnostics